Physician
Health Excel Ipa, INC.
Health Excel Ipa, INC. was paid $441K by Medicaid between Feb 2020 and Aug 2021, across 91 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 17% of everything it billed.
33Billing provider infoHEALTH EXCEL IPA, INC.
LA JOLLA, CA 92037
LA JOLLA, CA 92037
33aNPI1376031161assigned 04/26/2018
33bProvider typeColon & Rectal Surgery Physician
28Total paid$441K
24GClaims26,954
24DCodes billed91
24AFirst – last monthFeb 2020 – Aug 2021
Compared with peers
Next to other Colon & Rectal Surgery Physician providers in California
Rank by total paid#2 of 25
Median peer was paid$6K
This provider vs. median78×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 8,799 | $148K | |
| 2021 | 18,155 | $293K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 17% | 946 | 776 | $74K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 8.9% | 1,161 | 345 | $39K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 7.9% | 1,102 | 355 | $35K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 7.1% | 1,721 | 558 | $32K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 6.2% | 236 | 236 | $27K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.8% | 596 | 530 | $21K |
| 84443 | Thyroid stimulating hormone (TSH) | 3.8% | 1,487 | 1,473 | $17K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 3.7% | 591 | 570 | $16K |
| 80061 | Lipid panel | 3.6% | 1,502 | 1,494 | $16K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 3.6% | 572 | 553 | $16K |
| 80053 | Comprehensive metabolic panel | 3.2% | 1,967 | 1,879 | $14K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 3.1% | 738 | 222 | $14K |
79 more codes
| 99213 | Doctor's office visit, returning patient (routine) | 3.0% | 673 | $13K |
| J3490 | Unclassified drugs | 2.8% | 13 | $12K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 2.7% | 620 | $12K |
| 97010 | 2.4% | 937 | $10K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.1% | 1,827 | $9K |
| 97163 | 2.1% | 58 | $9K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.5% | 991 | $6K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 1.3% | 263 | $6K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 1.2% | 186 | $5K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 68 | $4K |
| 97164 | <1% | 26 | $3K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 134 | $3K |
| 86803 | <1% | 203 | $2K | |
| 84439 | <1% | 401 | $2K | |
| 99072 | <1% | 943 | $2K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 25 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 243 | $1K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 26 | $1K |
| 76830 | Ultrasound, transvaginal | <1% | 25 | $1K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 57 | $1K |
| 81001 | <1% | 520 | $1K | |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | <1% | 68 | $1K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 12 | $915.20 |
| 76642 | <1% | 12 | $799.90 | |
| 82607 | <1% | 85 | $714.09 | |
| 87340 | <1% | 95 | $693.22 | |
| 97014 | <1% | 46 | $666.08 | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 129 | $647.15 |
| A7038 | Filter, disposable, used with positive airway pressure device | <1% | 88 | $537.91 |
| 86592 | <1% | 148 | $465.41 | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 23 | $449.28 |
| 71046 | Radiologic examination, chest; 2 views | <1% | 25 | $447.27 |
| 99401 | <1% | 46 | $427.02 | |
| 84153 | <1% | 30 | $407.91 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 296 | $381.25 |
| 82274 | <1% | 34 | $363.49 | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 131 | $343.20 |
| 82043 | <1% | 81 | $330.30 | |
| 96156 | <1% | 16 | $325.00 | |
| 82746 | <1% | 33 | $259.63 | |
| 90686 | <1% | 13 | $258.39 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 28 | $258.06 |
| 87088 | <1% | 33 | $199.57 | |
| 96160 | <1% | 70 | $191.25 | |
| 83540 | <1% | 44 | $183.44 | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 13 | $177.76 |
| 85652 | <1% | 84 | $171.73 | |
| 81003 | <1% | 107 | $143.20 | |
| 82728 | <1% | 14 | $130.80 | |
| 82570 | <1% | 26 | $85.28 | |
| 84436 | <1% | 14 | $84.42 | |
| 83550 | <1% | 18 | $82.68 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 16 | $65.21 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 14 | $62.44 |
| 85027 | <1% | 17 | $46.53 | |
| 92015 | Determination of refractive state | <1% | 12 | $32.04 |
| 81002 | <1% | 14 | $30.10 | |
| 83735 | <1% | 16 | $14.98 | |
| 83690 | <1% | 13 | $13.20 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 1,998 | $0.00 |
| G9637 | Final reports with documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique) | 0% | 51 | $0.00 |
| 1111F | 0% | 263 | $0.00 | |
| 3008F | 0% | 363 | $0.00 | |
| 1036F | 0% | 164 | $0.00 | |
| 7025F | 0% | 220 | $0.00 | |
| 3341F | 0% | 12 | $0.00 | |
| S9088 | Services provided in an urgent care center (list in addition to code for service) | 0% | 232 | $0.00 |
| 1126F | 0% | 89 | $0.00 | |
| 3074F | 0% | 174 | $0.00 | |
| 98961 | 0% | 127 | $0.00 | |
| 99205 | Prolong outpt/office vis | 0% | 28 | $0.00 |
| 1220F | 0% | 28 | $0.00 | |
| 1125F | 0% | 13 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 30 | $0.00 |
| G9557 | Final reports for ct, cta, mri or mra studies of the chest or neck without an incidentally found thyroid nodule < 1.0 cm noted or no nodule found | 0% | 13 | $0.00 |
| 3078F | 0% | 158 | $0.00 | |
| 99051 | 0% | 97 | $0.00 | |
| G9551 | Final reports for imaging studies without an incidentally found lesion noted | 0% | 59 | $0.00 |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSOUNHEIN, THOMAS (CEO)
| Provider | Location | Paid |
|---|---|---|
| Ximed Hospitalists, INC. | La Jolla, CA | $880K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.